TipRanks
Biogen (MX:BIIB)
:BIIB
Mexico Market
BIIB
Biogen
RESEARCH TOOLSreports

Biogen (BIIB) Stock News & Sentiment

0 Followers
Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial
Premium
Company Announcements
Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial
1M ago
BIIB
Biogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data
Premium
Company Announcements
Biogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data
2M ago
BIIB
Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab
Premium
Weekend Updates
Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab
2M ago
GD
TMO
Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story
Premium
Company Announcements
Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story
2M ago
BIIB
Biogen Earnings Call: Growth Engines Offset Near-Term Drag
Premium
Company Announcements
Biogen Earnings Call: Growth Engines Offset Near-Term Drag
2M ago
BIIB
Biogen: Buy Rating Reiterated on Strong Q2 Beat and Upgraded 2026 Outlook; Price Target Maintained at $256
Premium
Ratings
Biogen: Buy Rating Reiterated on Strong Q2 Beat and Upgraded 2026 Outlook; Price Target Maintained at $256
2M ago
BIIB
Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors
Premium
Company Announcements
Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors
2M ago
BIIB
More MX:BIIB News >

BIIB News on the Web

Biogen publishes results from adolescent subgroup of VALIANT study
TipRanks News
Bullish
Biogen And Eisai Announce Japan Approval Of LEQEMBI Pen To Treat Early Alzheimer's Disease
rttnews
Bullish
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?
Insider Monkey
Bullish
Biogen Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Stryker (SYK), CVS Health (CVS) and Biogen (BIIB)
TipRanks News
Neutral
Stoke And Biogen Unveil Long-Term Zorevunersen Data In Dravet Syndrome
rttnews
Bullish
Stoke Therapeutics, Biogen present long-term data on Zorevunersen
TipRanks News
Bullish
Sphera Funds Management Boosts Tenax Therapeutics Stake in High-Risk Biotech Bet
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
MX:BIIB
Sector Average
Media Buzz
This Week2 articles
Weekly Average8 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:BIIB’s Media Buzz Sentiment?
2 articles about MX:BIIB were published this week. In an average week, 8 articles are published.
    What is MX:BIIB’s weekly average amount of articles?
    In an average week, 8 articles about MX:BIIB are published.
      What is MX:BIIB’s News Sentiment?
      100% of articles about MX:BIIB were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SMMTSummit Therapeutics
        CDNACareDx
        ARGXArgenx Se
        MEOBFMesoblast Limited
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week